Jyong Biotech Ltd. Ordinary Shares
NASDAQ:MENS · NASDAQ Global Select
-$0.02 today
Vol 0.12M · Avg 0.10M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-79.26%
Period High
$65.62
Period Low
$1.46
Latest
$1.56
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.19B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.58B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.34B
Legend Biotech Corporation
NASDAQ:LEGN
$5.14B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.06B
Celcuity Inc.
NASDAQ:CELC
$4.26B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.22B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.19B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.73B
Ascentage Pharma Group International
NASDAQ:AAPG
$404.16M
Explore More
Continue the stock analysis
Jump to another research area for this company.